This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
news supply-chain 
XTalks
JULY 24, 2023
Concordance Healthcare Solutions LLC, one of the largest independent healthcare distributors in the US, has officially launched Surgence, a groundbreaking healthcare supply chain ecosystem. How Will Surgence Optimize the Healthcare Supply Chain? Developed in collaboration with Palantir Technologies Inc.,
Pharmaceutical Commerce
APRIL 2, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
52 52 This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
FEBRUARY 4, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
69 
Pharmaceutical Commerce
JANUARY 23, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Outsourcing Pharma
APRIL 21, 2022
The latest news on expansions, innovations, awards, and more includes items from Eversana, DHL Supply Chain, X-Chem, Medidata, and other notable companies.
Scienmag
NOVEMBER 8, 2021
Over the past 18 months of news reporting and popular discussion, the phrase “global supply chain” has been as prominent as it has ever been. Pandemic-borne […].
87 87 
XTalks
DECEMBER 19, 2023
As we reflect on this dynamic year, it’s exciting to revisit the food news of 2023 that captivated our readers’ imaginations and sparked the most discussions. As the third most popular piece of food news in 2023, our audience was curious to know why the household staple was in short supply.
98 
XTalks
APRIL 6, 2021
The news of farmers dumping milk, letting crops rot and euthanizing chickens only added to the disarray. It seemed as though the food supply chain was broken when the world needed it the most. Growers pivoted to new buyers, shippers and distributors adapted and exports resumed. Was the Food Supply Chain Destined to Fail?
104 
World of DTC Marketing
JANUARY 8, 2021
At the time, pharmaceutical giant Pfizer and its partner BioNTech—which now have the other US-authorized COVID-19 vaccine—had inked a deal with the US government to supply doses at $19.50 Also, Johnson & Johnson had a deal to supply the US government with doses of its vaccine—still in the works—at a rate of $10 per dose.
266 
XTalks
NOVEMBER 23, 2020
But this time around, some grocery chains are implementing previously used tactics to curb the inevitable shortages of Thanksgiving staples and other food items. Since retailers could not have predicted the shortages and stockpiling that occurred back in March, they could not prepare for the inevitable supply chain disruptions that ensued.
98 
Outsourcing Pharma
APRIL 11, 2022
This monthâs news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.
52 
Pharmaceutical Technology
AUGUST 16, 2022
A lack of small and mid-cap companies among marketing authorisation holders is not normally good news for contractors, but even large and mega cap sponsors require outsourcing partners in certain conditions. This is especially the case in an age of supply chain disruption caused by the pandemic and the Russian-Ukrainian war.
162 
XTalks
JUNE 16, 2023
The good news though is that 100 percent of the centers are still able to treat patients who need cisplatin without any delays or claim denials, according to the survey. Supplies of carboplatin and cisplatin remain available in Canada because the country has multiple suppliers.
98 
Pharmaceutical Technology
DECEMBER 27, 2022
Tracking the news. Reynald Castaneda wrote about the affected clinical trial ecosystems in both countries , while Fiona Barry and Manasi analysed the impact of the war on the supply of the Russian Covid-19 vaccine Sputnik V to the rest of the world. Tracking drug development. See you in 2023!
306 
pharmaphorum
NOVEMBER 26, 2020
The two companies have been working together in this area since 2019, but BioNTech has opted to double down on the alliance with a revised agreement focusing on new immunotherapies for cancer and infectious diseases. This collaboration will expand our digital capabilities and optimise our operations across the value chain.”.
98 
The Pharma Data
NOVEMBER 20, 2020
As Pfizer and BioNTech announced news of a possible Covid-19 vaccine on November 8 , in haste, pharma leaders are rallying to ensure supply chains will be able to support distribution. Pharma leaders fear extreme vulnerability in end-to-end supply chain as pandemic continues, according to global survey.
52 
BioTech 365
SEPTEMBER 13, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Food systems and the bioeconomy.The COVID-19 pandemic has sharpened our focus on food—whether it be due to concerns relating to supply chain integrity, the viability of rural … Continue reading →
40 40 
pharmaphorum
OCTOBER 26, 2021
COVID-19 demonstrated the importance of robust supply chains and the dangers of an over reliance on overseas manufacturing. Only sustainable, robust supply chains and business models will allow innovation to flourish, secure access to medicines, and minimise the industry’s impact on the environment.
106 
BioTech 365
SEPTEMBER 29, 2020
EQS Group-News: Relief Therapeutics Holdings AG / Key word(s): Miscellaneous 30.09.2020 / 07:00 NeuroRx and Relief Therapeutics Establish Supply and Distribution Agreements for RLF-100(TM) (aviptadil) Development partners establish supply chain agreements and order sufficient drug substance to treat 1 million … Continue reading →
40 
pharmaphorum
FEBRUARY 24, 2021
AstraZeneca has said it will be able to meet a target to deliver 180 million COVID-19 vaccines to the EU in the second quarter, by topping up the supply from its global production network. The company has not said whether its commitments to the EU will affect supply to other countries around the world.
53 
BioTech 365
APRIL 6, 2021
EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Personnel 07.04.2021 / 07:00 Relief Engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant Geneva, Switzerland, April 07, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, … Continue reading →
Pharma Business Blog
MARCH 15, 2023
Dears Please find hereinafter the latest news related to Clinical Trials in the EU with a respective indirect tax and pharma regulatory licensing impact: 1. Non compliance with EU/EEA regulations lead to a potential supply chain disruption as well asl re-call of clinical trials material. Indirect tax point of view b.)
ACRP blog
SEPTEMBER 27, 2023
“As specialty drugs continue to be the main category in the FDA’s pipeline for new approvals as of mid-2023, and it has been projected that 13 new cell or gene therapies could be approved in the U.S., The need for risk management is paramount, he notes, given the multiple stakeholders involved in the supply chain.
Pharma Business Blog
JULY 2, 2021
Germany has recently published a court decision with major impact on the pharma supply chain (commercial and clinical) in the EU Member States: The court decision in a nutshell. Let’s discuss this crucial topic in more details during our next Pharma Webinar from a tax, regulatory affairs and supply chain point of view.
52 
pharmaphorum
DECEMBER 4, 2020
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. A Pfizer spokesperson told Reuters that the “scale-up of the raw material supply chain took longer than expected”.
103 
pharmaphorum
SEPTEMBER 10, 2020
That could be important if it takes longer than expected to bring vaccines and antibodies to market, said a spokesman for the companies, pointing to the news this week that AstraZeneca has halted phase 3 trials of its COVID-19 vaccine candidate AZD1222 after a serious adverse reaction in one patient.
130 
XTalks
JULY 20, 2021
The news outlet, in partnership with the nonprofit Food and Water Watch , revealed that only a few big food brands “control the majority market share of almost 80 percent of dozens of grocery items bought regularly by ordinary Americans.” So, what does this look like and what does it mean for smaller producers and businesses?
105 
Camargo
JANUARY 12, 2021
However, given that even domestic researchers are having difficulty obtaining the animals, it could be some time before the supply of NHPs from China returns to pre-pandemic levels. Given that data on marmosets continues to accumulate, the species may prove useful in diversifying the nonclinical research industry supply chain long-term.
130 
XTalks
FEBRUARY 5, 2021
As COVID-19 vaccines continue to be in short supply around the world, pharma giants such as Bayer (Nasdaq: BAYRY ) are stepping up to help fulfill the need. In early January, Bayer also struck an agreement with the company to support the further development, supply and key territory operations of CureVac’s COVID-19 vaccine candidate.
116 
The Pharma Data
DECEMBER 11, 2020
More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination. The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine.
52 
WCG Clinical
APRIL 3, 2023
Each business day, the new FDAnews will deliver precisely what pharmaceutical and medical device manufacturers have told us they need to know about regulatory compliance and good manufacturing practices,” said Terri Moench, RPh, MS, President, Research Solutions for WCG.
52 
XTalks
MARCH 25, 2022
Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process,” the company stated in a news release. Nitrosamines are commonly found in drinking water, air and foods such as dairy products, vegetables and cured and grilled meats.
The Pharma Data
AUGUST 14, 2020
With the World Health Organization this week publishing a list of the latest Covid-19 candidate vaccines from around the world , Pharma IQ’s weekly round-up looks at developments from the past seven days including news on how the pharma industry plans to handle vaccine disruption and flu season. Nathan De Valck, chairman of Pharma.Aero.,
52 
pharmaphorum
JUNE 14, 2021
The plant remains shuttered, so all the 21 million doses of J&J’s one-shot vaccine have been supplied from its facility in the Netherlands. The good news? It has also extended the expiration date for refrigerated supplies of the Janssen vaccine, saying that it can be kept for 4.5
52 
pharmaphorum
NOVEMBER 26, 2020
In the build-up to chancellor Rishi Sunak’s announcement in the House of Commons, the Association of the British Pharmaceutical Industry (ABPI) chief executive Richard Torbett warned that a no-deal Brexit could disrupt supplies of vaccines. ” The ABPI had better things to say about the spending review, however.
104 
pharmaphorum
DECEMBER 10, 2020
There’s no indication yet who was behind the EMA hack, but a volunteer group set up to tackle cybercrime related to COVID-19 – CTI League – has suggested that one motivation could be to uncover details about the supply and distribution of vaccines.
109 
XTalks
SEPTEMBER 22, 2020
Benedetto Marelli, an assistant professor in MIT’s Department of Civil and Environmental Engineering notes on MIT News , “There is a lot of food that’s wasted due to lack of proper labeling, and we’re throwing food away without even knowing if it’s spoiled or not.”
Pharmaceutical Technology
DECEMBER 12, 2022
The data, which is collated from the GlobalData Pharma Intelligence Center’s Deals Database and PharmSource reports on these outsourcing relationships, provides a glimpse of not only the different players involved in the pharma supply value chain, but also the nature of the contracts that link them.
147 
Camargo
FEBRUARY 4, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. In the News: March 2021 Regulatory and Development Updates. In the News: February 2021 Regulatory and Development Updates.
131 
The Pharma Data
MAY 2, 2023
Through this initiative, Boehringer Ingelheim plays a vital role in strengthening Germany’s long-term position as a prominent research and production location for the reliable supply of medicines to patients across the globe. Developing new drugs is a critical technology of the 21 st century.
Pharma Business Blog
APRIL 8, 2020
Even though there has been no news about the development in the EU-Swiss negotiations, which could secure specific status of the Swiss manufacturers, due to the COVID 19 outbreak the Commission announced on 25 March 2020 that it works on a proposal to postpone the application date of the Medical Devices Regulation (MDR) for one year.
pharmaphorum
FEBRUARY 4, 2021
From my perspective, specialization is a key part of this: it’s never been more important for supply chain partners to understand the terrain, know the challenges and be able to operate as intelligent business partners to pharma, CROs and med tech firms as they negotiate their way forward in 2021.
52 
The Pharma Data
AUGUST 21, 2020
However, in this week’s round up, Pharma IQ shares promising news of a Covid-19 candidate collaboration between Roche and Regeneron that looks to boost manufacturing and delivery efforts to patients in need of a cure. Roche and Regeneron join forces to increase global supply of an antibody cocktail for Covid-19.
52 
XTalks
MAY 11, 2021
Recognizing the impact of the pandemic on manufacturing and global supply chains in the production and delivery of drugs and vaccines for COVID-19, Lonza CEO Pierre-Alain Ruffieux said the company decided to take action to expand its manufacturing rosters. “In
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content